Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Judith Regensteiner

Concepts (532)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intermittent Claudication
46
2022
122
4.830
Why?
Diabetes Mellitus, Type 2
55
2025
2588
4.300
Why?
Sex Characteristics
18
2024
782
3.180
Why?
Peripheral Arterial Disease
24
2022
507
3.120
Why?
Exercise
47
2024
2198
2.980
Why?
Exercise Therapy
31
2022
475
2.720
Why?
Peripheral Vascular Diseases
25
2011
104
2.420
Why?
Sex Factors
20
2024
2105
2.160
Why?
Oxygen Consumption
33
2021
718
2.020
Why?
Cardiovascular Diseases
23
2024
2187
1.880
Why?
Walking
23
2022
542
1.830
Why?
Diabetes Mellitus
18
2024
1097
1.780
Why?
Women's Health
10
2024
314
1.740
Why?
Biomedical Research
8
2024
717
1.370
Why?
Exercise Test
38
2019
630
1.350
Why?
Cardiology
6
2023
362
1.100
Why?
Exercise Tolerance
15
2024
283
1.100
Why?
American Heart Association
10
2019
358
1.070
Why?
Quality of Life
18
2019
3204
0.990
Why?
Leg
13
2021
242
0.980
Why?
Research Personnel
5
2024
184
0.980
Why?
Humans
185
2025
145475
0.870
Why?
Adverse Drug Reaction Reporting Systems
1
2024
81
0.830
Why?
Mentoring
3
2022
165
0.830
Why?
United States Food and Drug Administration
1
2024
208
0.800
Why?
Diabetic Angiopathies
6
2017
264
0.800
Why?
Vascular Stiffness
3
2023
486
0.790
Why?
Male
104
2025
72843
0.760
Why?
Female
108
2025
78845
0.760
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2024
443
0.740
Why?
Muscle, Skeletal
14
2024
1789
0.740
Why?
Cardiovascular System
5
2023
138
0.730
Why?
Community Health Services
2
2015
231
0.730
Why?
Diabetic Cardiomyopathies
3
2016
34
0.720
Why?
Education, Medical
3
2020
275
0.700
Why?
Periodicals as Topic
1
2024
209
0.700
Why?
Insulin Resistance
12
2024
1244
0.660
Why?
Cardiorespiratory Fitness
3
2025
74
0.640
Why?
Lower Extremity
9
2019
445
0.640
Why?
Interdisciplinary Research
1
2020
26
0.620
Why?
Arterial Occlusive Diseases
7
2015
90
0.620
Why?
Sitagliptin Phosphate
1
2019
31
0.590
Why?
Endothelium, Vascular
6
2021
956
0.580
Why?
Middle Aged
74
2025
36215
0.580
Why?
Obesity
19
2023
3116
0.580
Why?
Aged
57
2024
26153
0.570
Why?
Diastole
1
2019
146
0.570
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
46
0.570
Why?
Ventricular Dysfunction, Left
2
2025
394
0.560
Why?
Surveys and Questionnaires
23
2018
6066
0.540
Why?
Physical Fitness
9
2016
207
0.540
Why?
Gender Identity
1
2019
128
0.540
Why?
United States
37
2024
16098
0.520
Why?
Hypertension
6
2022
1273
0.510
Why?
Brachial Artery
6
2015
208
0.510
Why?
Metabolomics
2
2020
732
0.510
Why?
Hypoglycemic Agents
9
2021
1399
0.510
Why?
Physical Exertion
7
2009
205
0.500
Why?
Mitochondria, Muscle
4
2024
120
0.500
Why?
Health Status
4
2020
832
0.500
Why?
Blood Pressure
12
2021
1779
0.500
Why?
Venoms
1
2016
22
0.490
Why?
Vasodilator Agents
4
2010
330
0.480
Why?
Curriculum
2
2020
1070
0.470
Why?
Biomarkers
6
2024
4295
0.450
Why?
Research Design
5
2024
1137
0.430
Why?
Cardiac Rehabilitation
3
2019
46
0.430
Why?
Life Style
9
2018
485
0.420
Why?
National Institutes of Health (U.S.)
4
2023
147
0.410
Why?
Arteriosclerosis
5
2002
83
0.410
Why?
Physicians
5
2024
955
0.390
Why?
Faculty, Medical
6
2024
303
0.380
Why?
Sleep
1
2020
888
0.380
Why?
Home Care Services
4
2019
284
0.370
Why?
Microcirculation
4
2017
142
0.370
Why?
Diabetes Mellitus, Type 1
9
2024
3922
0.360
Why?
Risk Factors
29
2022
10885
0.360
Why?
Advisory Committees
5
2019
229
0.360
Why?
Mentors
4
2022
217
0.360
Why?
Overweight
7
2025
614
0.350
Why?
Blood Flow Velocity
4
2009
421
0.350
Why?
Longevity
3
2024
178
0.350
Why?
Adult
41
2025
40777
0.320
Why?
Peptides
1
2016
998
0.320
Why?
Disability Evaluation
2
2011
310
0.320
Why?
Ankle
3
2008
64
0.320
Why?
Weight Loss
6
2016
858
0.310
Why?
Gait
2
2006
312
0.300
Why?
Treatment Outcome
24
2022
11772
0.300
Why?
Regional Blood Flow
11
2020
514
0.290
Why?
Tetrazoles
3
2006
50
0.290
Why?
Cardiac Output, Low
1
2009
53
0.290
Why?
Research Support as Topic
2
2020
80
0.280
Why?
Thiazolidinediones
3
2010
139
0.280
Why?
Physical Endurance
3
2011
279
0.280
Why?
Double-Blind Method
8
2019
2062
0.270
Why?
Ventricular Function, Left
2
2025
542
0.270
Why?
Oxygen
4
2018
978
0.270
Why?
Recovery of Function
9
2019
716
0.270
Why?
Cost of Illness
3
2018
324
0.270
Why?
Fear
1
2011
368
0.260
Why?
Oxidative Phosphorylation
2
2019
209
0.260
Why?
Glucagon-Like Peptide 1
2
2020
149
0.250
Why?
Hematologic Agents
1
2006
3
0.250
Why?
Follow-Up Studies
9
2024
5423
0.250
Why?
Activities of Daily Living
5
2021
444
0.240
Why?
Perception
1
2009
378
0.240
Why?
Blood Glucose
10
2024
2341
0.240
Why?
Stents
6
2015
564
0.240
Why?
Medicare
2
2022
903
0.230
Why?
Disease Management
4
2017
653
0.230
Why?
Motor Activity
5
2012
718
0.230
Why?
Myocardial Perfusion Imaging
1
2025
50
0.230
Why?
Foundations
2
2018
27
0.220
Why?
Vascular Diseases
4
2000
252
0.220
Why?
Caregivers
3
2024
1073
0.220
Why?
Predictive Value of Tests
6
2025
2121
0.220
Why?
Pharmacovigilance
1
2024
24
0.220
Why?
Interdisciplinary Studies
2
2017
30
0.220
Why?
Vascular Surgical Procedures
5
2009
343
0.210
Why?
Echocardiography
4
2018
647
0.210
Why?
Troponin
1
2024
50
0.210
Why?
Societies, Medical
3
2017
899
0.210
Why?
Feasibility Studies
2
2022
1111
0.210
Why?
Vasodilation
3
2015
521
0.210
Why?
Troponin T
1
2024
63
0.210
Why?
Respiration
3
1990
206
0.210
Why?
Magnetic Resonance Imaging, Cine
1
2025
214
0.210
Why?
Troponin I
1
2024
73
0.200
Why?
Heart Rate
6
2015
855
0.200
Why?
Fibrinolysis
2
2003
164
0.200
Why?
Kinetics
5
2015
1567
0.200
Why?
Insulin
5
2020
2512
0.200
Why?
Medroxyprogesterone
4
1991
11
0.200
Why?
Pulse Wave Analysis
3
2023
267
0.200
Why?
Chest Pain
1
2024
99
0.200
Why?
Muscles
7
1994
330
0.190
Why?
Lung Diseases
3
2019
780
0.190
Why?
Iliac Artery
2
2014
55
0.190
Why?
Polyhydroxyethyl Methacrylate
1
2002
10
0.190
Why?
Minority Groups
2
2022
284
0.190
Why?
Financing, Organized
2
2020
36
0.190
Why?
Financial Management
1
2022
16
0.190
Why?
Phosphodiesterase Inhibitors
1
2002
73
0.180
Why?
Glucose Intolerance
1
2024
142
0.180
Why?
Vitamin E
1
2003
125
0.180
Why?
Case-Control Studies
8
2025
3623
0.180
Why?
Orthopedics
1
2024
173
0.170
Why?
Estrogens, Conjugated (USP)
3
1991
52
0.170
Why?
Organizational Innovation
2
2020
119
0.170
Why?
Congresses as Topic
2
2020
223
0.170
Why?
Endovascular Procedures
2
2018
390
0.170
Why?
Arginine
1
2003
264
0.170
Why?
Placebos
3
2019
193
0.170
Why?
Ascorbic Acid
1
2003
184
0.170
Why?
Academic Medical Centers
3
2020
554
0.170
Why?
Adiponectin
2
2016
241
0.170
Why?
Severity of Illness Index
4
2009
2930
0.160
Why?
Sulfonylurea Compounds
2
2019
51
0.160
Why?
Interdisciplinary Communication
2
2020
200
0.160
Why?
Echocardiography, Doppler
3
2016
115
0.160
Why?
Sex Distribution
2
2020
387
0.160
Why?
Cross-Sectional Studies
9
2025
5905
0.160
Why?
Neovascularization, Physiologic
2
2012
192
0.160
Why?
Qualitative Research
3
2024
1674
0.160
Why?
Cardiovascular Agents
2
2014
166
0.160
Why?
Precision Medicine
2
2024
459
0.150
Why?
Patient Compliance
4
2015
587
0.150
Why?
Time Factors
11
2018
7123
0.150
Why?
Arteries
3
2016
261
0.150
Why?
Forearm
2
2015
141
0.150
Why?
Hemodynamics
6
2009
1118
0.150
Why?
Clinical Trials as Topic
6
2019
1061
0.150
Why?
Body Composition
5
2014
693
0.140
Why?
Pediatric Obesity
2
2017
638
0.140
Why?
Randomized Controlled Trials as Topic
7
2006
1747
0.140
Why?
Telerehabilitation
1
2019
47
0.140
Why?
Body Mass Index
9
2017
2445
0.140
Why?
Adolescent
12
2022
22530
0.140
Why?
Cause of Death
1
2020
470
0.130
Why?
Women's Rights
1
2017
4
0.130
Why?
Diabetes Complications
4
2010
224
0.130
Why?
Leadership
2
2020
401
0.130
Why?
Pentoxifylline
3
2006
23
0.130
Why?
Magnetic Resonance Spectroscopy
2
2024
627
0.130
Why?
Health Status Indicators
4
2015
167
0.130
Why?
Burnout, Professional
1
2024
488
0.130
Why?
Program Development
1
2019
368
0.130
Why?
Resistance Training
1
2020
186
0.130
Why?
Sexism
1
2018
68
0.130
Why?
Heart Diseases
2
2019
341
0.130
Why?
Aged, 80 and over
9
2012
8333
0.120
Why?
Death, Sudden, Cardiac
1
2018
232
0.120
Why?
Colorado
9
2017
4554
0.120
Why?
Interviews as Topic
4
2024
910
0.120
Why?
Ankle Brachial Index
2
2014
41
0.120
Why?
Circadian Rhythm
2
2020
512
0.120
Why?
Capillaries
3
2012
125
0.120
Why?
Microvessels
1
2017
97
0.120
Why?
Glucose Tolerance Test
4
2024
360
0.120
Why?
Blood Vessels
1
2017
167
0.120
Why?
Faculty
1
2017
147
0.110
Why?
Reference Values
4
2007
798
0.110
Why?
Ischemia
1
2019
422
0.110
Why?
Leptin
1
2017
248
0.110
Why?
Plethysmography
3
2011
104
0.110
Why?
Adiposity
2
2017
532
0.110
Why?
Practice Guidelines as Topic
3
2019
1581
0.110
Why?
Intention to Treat Analysis
1
2015
79
0.110
Why?
Program Evaluation
2
2020
943
0.110
Why?
Needs Assessment
1
2018
402
0.110
Why?
Myocardium
1
2020
934
0.110
Why?
Ventricular Function
1
2015
53
0.110
Why?
Health Status Disparities
1
2018
321
0.110
Why?
Cardiac Output
1
2015
179
0.110
Why?
Physical Education and Training
1
1994
70
0.110
Why?
Endothelium
1
2015
119
0.100
Why?
Arterial Pressure
1
2015
134
0.100
Why?
Healthy Volunteers
1
2015
219
0.100
Why?
Oxidative Stress
1
2021
1356
0.100
Why?
Pilot Projects
2
2015
1891
0.100
Why?
Peripheral Nervous System Diseases
1
1995
134
0.100
Why?
Hyperlipidemias
3
2004
120
0.100
Why?
Patient Selection
4
2019
738
0.100
Why?
Diagnostic Self Evaluation
1
2013
23
0.100
Why?
Health Care Costs
2
2014
425
0.100
Why?
Angioplasty
2
2009
50
0.100
Why?
Aortic Diseases
1
2014
125
0.100
Why?
Hypoxia
3
1990
1199
0.100
Why?
Menopause
3
1991
326
0.100
Why?
Diet, Reducing
1
2013
91
0.090
Why?
Reaction Time
1
2015
433
0.090
Why?
Carnitine
5
2001
91
0.090
Why?
Smoking
6
2010
1472
0.090
Why?
Capacity Building
1
2012
62
0.090
Why?
Diabetic Nephropathies
2
2014
322
0.090
Why?
Premenopause
2
2003
125
0.090
Why?
Students, Medical
1
2017
378
0.090
Why?
Counseling
1
2015
400
0.090
Why?
Heart Ventricles
1
2016
756
0.090
Why?
Myocardial Revascularization
1
2011
85
0.090
Why?
Kidney
2
2021
1497
0.080
Why?
Linear Models
2
2014
845
0.080
Why?
Research Report
1
2011
86
0.080
Why?
Consensus
3
2019
477
0.080
Why?
Clinical Protocols
1
1993
280
0.080
Why?
Retrospective Studies
4
2024
17291
0.080
Why?
Benchmarking
1
2012
191
0.080
Why?
Health Promotion
1
2017
775
0.080
Why?
Fatty Acids, Nonesterified
2
2009
154
0.080
Why?
Sickness Impact Profile
1
2011
62
0.080
Why?
Comorbidity
4
2021
1661
0.080
Why?
Hyperemia
1
2011
49
0.080
Why?
Self Concept
1
2012
253
0.080
Why?
Hemoglobins
2
2017
386
0.080
Why?
Coronary Disease
4
2004
381
0.080
Why?
Atherosclerosis
2
2011
409
0.080
Why?
Niacin
1
2010
16
0.080
Why?
Lovastatin
1
2010
37
0.080
Why?
Hypertrophy, Left Ventricular
2
2009
124
0.080
Why?
Affect
1
2012
320
0.080
Why?
C-Reactive Protein
2
2009
422
0.080
Why?
Young Adult
6
2024
14219
0.070
Why?
Body Fat Distribution
1
2009
46
0.070
Why?
Gonadal Steroid Hormones
1
1990
143
0.070
Why?
Vascular Endothelial Growth Factor A
1
2012
552
0.070
Why?
Platelet Aggregation Inhibitors
3
2002
499
0.070
Why?
Heart Function Tests
1
2009
59
0.070
Why?
Hyperinsulinism
2
2010
114
0.070
Why?
Pulmonary Wedge Pressure
1
2009
66
0.070
Why?
Thinness
1
2009
100
0.070
Why?
Analysis of Variance
4
2012
1300
0.070
Why?
Aorta
1
2011
440
0.070
Why?
Fasting
2
2005
279
0.070
Why?
Psychometrics
1
2012
731
0.070
Why?
Age Factors
4
2021
3342
0.070
Why?
Heart Failure
3
2018
2326
0.070
Why?
Hospitalization
1
2018
2460
0.070
Why?
Puberty
1
2009
137
0.070
Why?
Myoglobin
1
2007
12
0.070
Why?
Perfusion
1
2009
251
0.070
Why?
Angina Pectoris
1
2008
76
0.070
Why?
Cost-Benefit Analysis
4
2014
639
0.070
Why?
Leisure Activities
2
2006
30
0.060
Why?
Mitochondria
1
2014
992
0.060
Why?
Inflammation
3
2009
2878
0.060
Why?
Awareness
1
2008
110
0.060
Why?
Aging
1
2018
1969
0.060
Why?
Regression Analysis
5
1998
1001
0.060
Why?
Prospective Studies
8
2019
8057
0.060
Why?
Health Knowledge, Attitudes, Practice
2
2008
1419
0.060
Why?
Prevalence
3
2019
2865
0.060
Why?
Dyspnea
1
2008
250
0.060
Why?
Chronic Disease
2
2023
1808
0.060
Why?
Blood Viscosity
2
1995
19
0.060
Why?
Glycation End Products, Advanced
1
2006
81
0.060
Why?
Metformin
2
2010
329
0.060
Why?
Pulmonary Circulation
1
2007
430
0.060
Why?
Glucose Clamp Technique
1
2005
199
0.060
Why?
Hematocrit
2
1995
108
0.050
Why?
Interleukin-6
1
2009
776
0.050
Why?
Sulfonic Acids
1
2004
14
0.050
Why?
Guilt
1
2024
10
0.050
Why?
Multicenter Studies as Topic
2
2004
412
0.050
Why?
Neoplasms
2
2010
2906
0.050
Why?
Nutrition Surveys
1
2006
279
0.050
Why?
Animals
5
2018
38030
0.050
Why?
Population Dynamics
1
1985
142
0.050
Why?
Acetates
1
2004
78
0.050
Why?
Work-Life Balance
1
2024
22
0.050
Why?
Estrogens
2
2010
367
0.050
Why?
Lipids
1
2009
707
0.050
Why?
Health Maintenance Organizations
1
2004
105
0.050
Why?
Biopsy
3
2012
1082
0.050
Why?
Incidence
3
2019
2923
0.050
Why?
Cohort Studies
3
2016
6013
0.050
Why?
Dietary Carbohydrates
1
2004
147
0.050
Why?
Body Weight
2
2006
971
0.050
Why?
Mitochondrial Diseases
1
2024
92
0.050
Why?
Physicians, Women
1
2024
89
0.050
Why?
Intracranial Arterial Diseases
1
2002
8
0.050
Why?
Genetic Vectors
1
2004
335
0.050
Why?
Dietary Fats
1
2004
308
0.050
Why?
Neovascularization, Pathologic
1
2004
286
0.050
Why?
Child
5
2017
22707
0.050
Why?
Serum Globulins
1
2002
5
0.050
Why?
Glycolysis
1
2024
340
0.050
Why?
Musculoskeletal Diseases
1
2003
90
0.040
Why?
Genetic Therapy
1
2004
316
0.040
Why?
Psychomotor Performance
1
2004
324
0.040
Why?
Plasminogen Activator Inhibitor 1
1
2002
85
0.040
Why?
Prognosis
2
2010
4316
0.040
Why?
Lung
1
2015
4106
0.040
Why?
Single-Blind Method
2
2013
318
0.040
Why?
Pelvis
1
2002
125
0.040
Why?
Proteinuria
1
2001
104
0.040
Why?
Fibroblast Growth Factor 2
1
2001
94
0.040
Why?
Diet
2
2010
1277
0.040
Why?
Homocysteine
1
2002
152
0.040
Why?
Adipose Tissue
1
2005
645
0.040
Why?
Physical Examination
1
2002
243
0.040
Why?
Enzyme Inhibitors
1
2004
820
0.040
Why?
Alcohol Drinking
2
2010
837
0.040
Why?
Meta-Analysis as Topic
1
2002
171
0.040
Why?
Ambulatory Care
2
2014
609
0.040
Why?
Patient Satisfaction
2
2002
709
0.040
Why?
Fibrinogen
1
2002
180
0.040
Why?
Altitude
1
1985
463
0.040
Why?
Multivariate Analysis
3
2014
1547
0.040
Why?
Cardiovascular Surgical Procedures
1
2000
30
0.040
Why?
Aorta, Thoracic
1
2023
286
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
229
0.040
Why?
Cholesterol, LDL
2
2014
360
0.040
Why?
Administration, Oral
1
2003
866
0.040
Why?
Carrier Proteins
1
2004
728
0.040
Why?
Tissue Plasminogen Activator
1
2002
248
0.040
Why?
Myocardial Ischemia
1
2002
285
0.040
Why?
Medroxyprogesterone Acetate
2
1990
33
0.040
Why?
Organization and Administration
1
2019
14
0.040
Why?
Specialties, Surgical
1
2000
82
0.040
Why?
Internal Medicine
1
2002
279
0.040
Why?
Femoral Artery
2
2011
190
0.040
Why?
Pregnancy
3
2020
7202
0.040
Why?
Apoptosis
1
2007
2440
0.040
Why?
Sports Medicine
2
2010
118
0.040
Why?
Asia
1
2018
70
0.040
Why?
Risk Adjustment
1
2019
85
0.040
Why?
Densitometry
1
1998
36
0.030
Why?
Lactic Acid
2
1998
295
0.030
Why?
Patient Outcome Assessment
1
2019
130
0.030
Why?
Hypercapnia
2
1989
53
0.030
Why?
Coronary Vessels
1
2020
246
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2001
345
0.030
Why?
Rural Population
2
1995
659
0.030
Why?
Walking Speed
1
2018
53
0.030
Why?
Cell Respiration
1
2018
105
0.030
Why?
Autonomic Nervous System
1
1998
82
0.030
Why?
Public Health
1
2023
572
0.030
Why?
Smoking Cessation
1
2002
440
0.030
Why?
Walk Test
1
2018
81
0.030
Why?
Secondary Prevention
1
2019
251
0.030
Why?
Family Practice
1
2001
407
0.030
Why?
Hand Strength
1
2018
144
0.030
Why?
Drug Therapy, Combination
2
2010
1044
0.030
Why?
Neural Conduction
2
1995
92
0.030
Why?
Capillary Resistance
1
2017
4
0.030
Why?
Social Stigma
1
2020
172
0.030
Why?
Career Choice
1
2019
234
0.030
Why?
Oxyhemoglobins
1
2017
28
0.030
Why?
Betacoronavirus
1
2020
288
0.030
Why?
Acute Disease
1
2020
1036
0.030
Why?
Pragmatic Clinical Trials as Topic
1
2017
133
0.030
Why?
Depression
1
2007
1546
0.030
Why?
Caloric Restriction
1
2018
133
0.030
Why?
Reproducibility of Results
2
2013
3413
0.030
Why?
Weight Reduction Programs
1
2018
140
0.030
Why?
Spectroscopy, Near-Infrared
1
2017
70
0.030
Why?
Canada
1
2018
431
0.030
Why?
Heart
1
2020
626
0.030
Why?
Bicycling
1
2017
117
0.030
Why?
Forecasting
2
2000
390
0.030
Why?
Sensitivity and Specificity
2
2013
1997
0.030
Why?
Vascular Resistance
1
2017
370
0.030
Why?
Social Support
1
2020
646
0.030
Why?
Matched-Pair Analysis
1
1995
37
0.030
Why?
Stroke Volume
1
2018
654
0.030
Why?
Pneumonia, Viral
1
2020
389
0.030
Why?
Coronavirus Infections
1
2020
383
0.030
Why?
Risk
1
2017
919
0.030
Why?
Absorptiometry, Photon
1
2016
277
0.030
Why?
Energy Intake
3
2006
512
0.030
Why?
Electrophysiology
1
1995
218
0.030
Why?
Cystatin C
1
2014
66
0.030
Why?
Vascular Patency
1
2014
121
0.030
Why?
Quality-Adjusted Life Years
1
2014
123
0.030
Why?
Models, Economic
1
2014
61
0.030
Why?
Phosphorus
1
2014
90
0.030
Why?
Life Expectancy
1
2014
73
0.030
Why?
Patient Education as Topic
1
2019
777
0.030
Why?
Hospital Costs
1
2014
125
0.030
Why?
Stress, Mechanical
1
2016
494
0.030
Why?
Constriction, Pathologic
1
2014
249
0.030
Why?
Databases, Factual
2
2011
1490
0.020
Why?
Health Behavior
1
2019
789
0.020
Why?
Drug Costs
1
2014
117
0.020
Why?
Cyclic AMP Response Element-Binding Protein
1
2014
146
0.020
Why?
Health Education
1
2016
346
0.020
Why?
Nitric Oxide Synthase Type III
1
2014
203
0.020
Why?
Collateral Circulation
2
2003
20
0.020
Why?
Evidence-Based Medicine
1
2016
740
0.020
Why?
Creatinine
1
2014
515
0.020
Why?
Administrative Personnel
1
2012
33
0.020
Why?
Carotid Stenosis
1
2014
107
0.020
Why?
Statistics as Topic
1
2013
283
0.020
Why?
Biomechanical Phenomena
1
2016
857
0.020
Why?
Blood Vessel Prosthesis
1
2013
140
0.020
Why?
Waist Circumference
1
2012
143
0.020
Why?
Treatment Failure
1
2013
360
0.020
Why?
Health Planning
1
1992
47
0.020
Why?
North Carolina
1
2012
129
0.020
Why?
Internship and Residency
1
2002
1267
0.020
Why?
Pandemics
1
2020
1707
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
74
0.020
Why?
Muscle Contraction
1
2014
429
0.020
Why?
Muscle Strength
1
2014
332
0.020
Why?
Popliteal Artery
1
2011
62
0.020
Why?
Cerebrovascular Disorders
1
1992
104
0.020
Why?
Estrone
1
1991
41
0.020
Why?
Radioimmunoassay
1
1991
165
0.020
Why?
Behavior Therapy
1
2014
296
0.020
Why?
Glomerular Filtration Rate
1
2014
765
0.020
Why?
Follicular Phase
1
1990
41
0.020
Why?
Kaplan-Meier Estimate
1
2013
969
0.020
Why?
Metabolism
1
1990
44
0.020
Why?
Luteal Phase
1
1990
51
0.020
Why?
C-Peptide
1
1991
190
0.020
Why?
Incretins
1
2010
21
0.020
Why?
Receptor, IGF Type 1
1
2010
64
0.020
Why?
Receptor, Insulin
1
2010
93
0.020
Why?
Health Services Research
1
2012
391
0.020
Why?
Acetylcarnitine
1
1989
6
0.020
Why?
Adaptation, Physiological
1
2014
560
0.020
Why?
Actigraphy
1
2010
148
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
848
0.020
Why?
Progesterone
1
1991
215
0.020
Why?
Percutaneous Coronary Intervention
1
2015
549
0.020
Why?
Delayed-Action Preparations
1
2010
189
0.020
Why?
Risk Assessment
2
2009
3747
0.020
Why?
Respiration Disorders
1
1989
78
0.020
Why?
Attitude of Health Personnel
1
2017
1193
0.020
Why?
Partial Pressure
1
1988
30
0.020
Why?
Energy Metabolism
3
2006
935
0.020
Why?
Estradiol
1
1991
515
0.020
Why?
Drug Interactions
1
1989
405
0.020
Why?
Tidal Volume
1
1988
109
0.020
Why?
Pain
1
1993
789
0.020
Why?
Ankle Joint
1
2008
122
0.020
Why?
Risk Reduction Behavior
1
2009
217
0.020
Why?
Fluoroquinolones
1
2007
44
0.020
Why?
Caspase 3
1
2007
242
0.020
Why?
Models, Cardiovascular
1
2007
196
0.020
Why?
Receptor for Advanced Glycation End Products
1
2006
33
0.010
Why?
Hyperglycemia
1
2010
379
0.010
Why?
Testosterone
1
2010
416
0.010
Why?
Longitudinal Studies
1
2014
2953
0.010
Why?
Carbon Dioxide
1
1988
227
0.010
Why?
Enzyme Activation
1
2007
762
0.010
Why?
Income
1
2007
202
0.010
Why?
Receptors, Immunologic
1
2006
208
0.010
Why?
Sterol O-Acyltransferase
1
2004
6
0.010
Why?
Sleep Wake Disorders
1
1989
314
0.010
Why?
Acetamides
1
2004
41
0.010
Why?
Case Management
1
2004
68
0.010
Why?
Age Distribution
1
2004
403
0.010
Why?
Cell Adhesion Molecules
1
2004
181
0.010
Why?
Calcium-Binding Proteins
1
2004
221
0.010
Why?
Gene Transfer Techniques
1
2004
187
0.010
Why?
Cognition Disorders
1
2007
541
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
376
0.010
Why?
Cytokines
1
2010
2067
0.010
Why?
Magnetic Resonance Imaging
1
2014
3904
0.010
Why?
Endpoint Determination
1
2001
85
0.010
Why?
Lactates
2
1992
82
0.010
Why?
Ultrasonography, Doppler
1
2001
126
0.010
Why?
World Health Organization
1
2000
104
0.010
Why?
Attitude
1
2002
259
0.010
Why?
Sulfonamides
1
2004
583
0.010
Why?
Wound Healing
1
2003
355
0.010
Why?
Algorithms
1
2008
1845
0.010
Why?
Costs and Cost Analysis
1
2000
221
0.010
Why?
Artificial Limbs
1
2003
208
0.010
Why?
Indians, North American
1
2004
597
0.010
Why?
Logistic Models
1
2004
2134
0.010
Why?
Models, Biological
1
2006
1764
0.010
Why?
Interpersonal Relations
1
2002
397
0.010
Why?
Socioeconomic Factors
1
2002
1323
0.010
Why?
Models, Theoretical
1
2000
558
0.010
Why?
Diabetic Neuropathies
1
1998
100
0.010
Why?
Diabetic Retinopathy
1
1998
209
0.010
Why?
Muscle Fibers, Skeletal
1
1996
212
0.010
Why?
Rehabilitation
1
1992
20
0.010
Why?
Cholesterol, HDL
1
1991
201
0.000
Why?
Hydroxybutyrates
1
1989
15
0.000
Why?
3-Hydroxybutyric Acid
1
1989
17
0.000
Why?
Electromyography
1
1992
419
0.000
Why?
Blood Gas Analysis
1
1989
81
0.000
Why?
Ultrasonics
1
1989
50
0.000
Why?
Nervous System Diseases
1
1992
286
0.000
Why?
Action Potentials
1
1992
502
0.000
Why?
Sleep Apnea Syndromes
1
1989
98
0.000
Why?
Drug Combinations
1
1989
396
0.000
Why?
Mice
1
1989
18329
0.000
Why?
Regensteiner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)